XPA: Bicruciate Preserving Arthroplasty

Why remove healthy ligaments?

Applying research in knee function and the role an anterior cruciate ligament (ACL) and a posterior cruciate ligament (PCL) has to native kinematics1-5, Biomet introduces its focus on a new arthroplasty, XPA – Bicruciate Preserving Arthroplasty. Biomet is committed to providing orthopedic surgeons with solutions for diverse patient populations and is proud to introduce its portfolio of bicruciate preserving knee solutions: the Oxford Partial Knee and Vanguard XP Total Knee System.

Explore the Oxford Partial Knee Solution

Explore the Vanguard XP Knee Solution

 

 

 

References

  1. Dargel, J. et al. Biomechanics of the Anterior Cruciate Ligament and Implications for Surgical Reconstruction. Strategies in Trauma and Limb Reconstruction. 2: 1-12, 2007.
  2. Kapandji, I.A. The Physiology of the Joints. 5th ed. Vol.2. Churchill Livingstone. 126, 1987.
  3. Katayama, K. et al., Proprioception and Performance after Anterior Cruciate Ligament Rupture. International Orthopaedics. 28: 278-281. 2004.
  4. Snyder-Mackler. L, et al. Reflex Inhibition of the Quadriceps Femoris Muscle after Injury or Reconstruction of the Anterior Cruciate Ligament. Journal of Bone and Joint Surgery [Am]. 76-A:555-60, 1994.
  5. Berchuck, M; Andriacchi, TP; Bach, BR; et al. Gait Adaptations by Patients Who Have a Deficient Anterior Cruciate Ligament, Journal of Bone and Joint Surgery – American Volume. 72A Issue: 871-877, July, 1990.

All content herein is protected by copyright, trademarks and other intellectual property rights, as applicable, owned by or licensed to Zimmer Biomet or its affiliates unless otherwise indicated, and must not be redistributed, duplicated or disclosed, in whole or in part, without the express written consent of Zimmer Biomet.  
This material is intended for health care professionals. Distribution to any other recipient is prohibited.
For product information, including indications, contraindications, warnings, precautions, potential adverse effects and patient counseling information, see the package insert and information on this website. To obtain a copy of the current Instructions for Use (IFU) for full prescribing and risk information, please call 1-800-348-2759, press 4 for 411 Technical Support.